Form 4: ClearPoint Neuro Director Acquires Shares in Lieu of Fees

Director Pascal E. R. Girin acquired 557 shares of ClearPoint Neuro, Inc. common stock on October 1, 2024, in lieu of fees owed under the company's Non-Employee Director Compensation Plan.

Summary

• On October 1, 2024, Pascal E. R. Girin, a director of ClearPoint Neuro, Inc., acquired 557 shares of common stock.
• The shares were issued as payment for fees owed to Girin under the company's Non-Employee Director Compensation Plan.
• The price per share was $11.21, based on the closing price of ClearPoint Neuro's common stock on September 30, 2024.
• Following the transaction, Girin directly owns 74,087 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. It shows the director's continued investment in the company, which is mildly positive, but it's not a major event.

Positives

• The acquisition reflects the director's continued investment in the company.
• Using shares to pay director fees conserves cash for the company.

Industry Context

This type of transaction, where directors receive shares in lieu of cash compensation, is a fairly common practice among publicly traded companies, especially smaller ones, as it helps conserve cash.

Related Party Transactions

• The issuance of shares to Pascal E. R. Girin, a director, in lieu of cash compensation is a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it conserves company cash.

Key Dates